Nitroglycerin Pediatric Dose — Cardiovascular Infusions
Nitroglycerin is an organic nitrate vasodilator that acts by releasing nitric oxide, leading to smooth muscle relaxation and venodilation, with arterial dilation occurring at higher doses. It is used in pediatric practice primarily for the management of hypertensive emergencies, acute heart failure, and conditions requiring preload and afterload reduction. Its rapid onset and titratable nature make it well suited for continuous infusion in monitored settings.
Pediatric Dosing
For pediatric patients, nitroglycerin is administered as a weight-based continuous infusion. For adult patients weighing ≥40 kg, dosing transitions to a fixed (non-weight-based) regimen.
- Pediatric (weight-based): 0.25–10 mcg/kg/min continuous IV infusion. Titrate to clinical effect.
- Adult (≥40 kg, non-weight-based): Initial infusion dose of 10 mcg/min. Commonly used maximum dose of 200 mcg/min. Note that dose is not weight-based in adults.
Worked example: For a 20 kg child, the starting infusion rate would typically begin at the lower end of the range: 20 kg × 0.25 mcg/kg/min = 5 mcg/min, titrated upward as needed to a maximum of 20 kg × 10 mcg/kg/min = 200 mcg/min. Consult institutional protocol for specific titration intervals and concentration guidance.
Indications and Clinical Context
Nitroglycerin is used in pediatric cardiovascular care for conditions requiring controlled reduction of preload and, at higher doses, afterload. Common indications include hypertensive urgency or emergency, acute decompensated heart failure, and pulmonary edema. Its primary mechanism of venodilation reduces right and left ventricular filling pressures, improving cardiac output in volume-overloaded states. It may also be used perioperatively in patients with congenital or acquired heart disease.
In the PICU setting, nitroglycerin infusions are typically employed as part of a broader hemodynamic management strategy. Clinicians should titrate carefully based on continuous blood pressure monitoring, symptom response, and hemodynamic parameters, as individual patient sensitivity can vary considerably.
Administration and Monitoring
Nitroglycerin must be administered as a continuous IV infusion via a dedicated or central line, as it adsorbs to standard PVC tubing — use non-PVC, non-DEHP infusion sets where available. Continuous arterial blood pressure monitoring is strongly recommended, particularly during titration. Abrupt discontinuation should be avoided; wean gradually to prevent rebound effects.
- Route: Continuous IV infusion only in this context
- Monitoring: Continuous blood pressure, heart rate, signs of hypotension or reflex tachycardia
- Key adverse effects: Hypotension, headache, reflex tachycardia, methemoglobinemia (with prolonged high-dose use)
- Contraindications: Concurrent use of phosphodiesterase-5 inhibitors, severe hypotension, hypovolemia
- Maximum dose: 200 mcg/min (commonly cited adult ceiling); consult institutional protocol for pediatric maximum dosing limits
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.